DHE in a dose of 10 mg daily was found to be effective in migraine prevention. Methysergide is another tested ergot derivative, but this drug is no longer available due to reports of retroperitoneal and retropleural fibrosis. Cyproheptadine
is a serotonin antagonist that has proven efficacy in the treatment of migraine, but sedation and weight gain have limited the use of this medication.